Logiq, Inc. (OTC PINK:LGIQ) (“Logiq” or “the Company”) proudly announces the definitive agreement to acquire EVIMATE (“EVIMATE”), a pioneer in medical device innovation. This acquisition, valued at $5 million, marks a significant milestone as Logiq diversifies into the medical devices sector. EVIMATE’s cutting-edge suite of vital sign products leverage advanced AI technology to provide comprehensive monitoring and predictive analytics across key health metrics. The solution combines next-generation devices with a user-friendly app to ensure continuous, accurate monitoring of temperature, heart rate, ECG, blood pressure, oxygen levels, and glucose levels.
Read the full article: Logiq, Inc. Acquires EVIMATE, Heralding a New Era in Medical Device Innovation //
Source: https://www.accesswire.com/929071/logiq-inc-acquires-evimate-heralding-a-new-era-in-medical-device-innovation